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Abstract
Background: Injections into the tendinous portion of the common extensor origin are a common intervention in
the treatment of Lateral Elbow Tendinopathy (LET). Clinical trials report a heterogeneous selection of injectate
volumes and delivery techniques, with systematic reviews finding no clear consensus. The aim of this study was to
assess the intratendinous distribution and surrounding tissue contamination of ultrasound-guided injections into
the Common Extensor Tendon (CET) of the elbow.
Methods: Twenty cadaveric elbows were injected by a Consultant Radiologist under Ultrasound guidance. Elbows
were randomised to equal groups of 1 or 3 mls of methylene blue injection, delivered using single shot or
fenestrated techniques. Following injection, each cadaver underwent a dry arthroscopy and dissection of superficial
tissues. The CET was excised, set and divided into 1 mm sections using microtome. Each slice was photographed
and analysed to assess spread and pixel density of injectate in four colour graduations. The cross-sectional area of
distribution was calculated and compared between groups.
Results: In all 20 cadaveric samples, contamination of the joint was noted on arthroscopy and dissection. Injectate
spread through over 97% of the cross-sectional area. No differences were found in intratendinous spread of
injectate between differing volumes or techniques.
Conclusion: This study found that commonly used injection volumes and techniques distribute widely throughout
cadaveric CETs. There was no improvement when the volume was increased from 1 to 3 mls or between single
shot of fenestrated injection techniques. It should be noted that joint contamination using these techniques and
volumes may be inevitable.
Background
Injection therapy for chronic lateral elbow tendinopathy
(LET), known commonly as tennis elbow, remains a
popular treatment choice (Sahbudin & Peall, 2013;
Titchener et al., 2015). Though corticosteroids were his-
torically the most common preparation, recent evidence
of its negative long-term sequelae (Bisset et al., 2011)
may see its usage decline. However, the emergence of
novel therapies such as platelet-rich plasma (PRP),
autologous blood (AB), botulinum toxin, glycosamino-
glycan polysulphate, sodium hyaluronic or prolotherapy
continue to promote interest in injection treatment. Sys-
tematic reviews of these therapeutic options remain in-
conclusive, with a recurring criticism of the
heterogeneity of injection dosing and technique between
studies (Ahmad et al., 2013; de Vos et al., 2014; Dong et
al., 2016; Fitzpatrick et al., 2017; Long et al., 2015).
Pathological change in LET occurs within the proximal
tendons of the common wrist extensor muscles, with
particular reference to the extensor carpi radialis brevis
(ECRB). Hence this is the intended site of injection ther-
apy in LET. The ECRB tendon originates from the lat-
eral epicondyle, lying deep to the remaining common
extensor tendons and superficial to the thin articular
capsule of the elbow (Nimura et al., 2014). Injection vol-
umes delivered to this area commonly range from 0.5–
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3.5mls (Dong et al., 2016) and employ either a single
shot or fenestrated (pepper pot) administration tech-
niques (Dong et al., 2016; Fitzpatrick et al., 2017). Ca-
daveric assessment has only been undertaken for
anatomically guided injections (Keijsers et al., 2017). The
injections were delivered by experienced clinicians using
their standard techniques, the study reported poor local-
isation of injectate, within only 33% (partially) localised
to the ECRB tendon and 60% localised intra-articular.
The location of the injectate in lateral elbow injections is
of clear importance. Under the premise that many of these
substances confer benefit due to their active constituents, it
is of vital importance that the retention and distribution of
injectate within the tendon is quantified, and furthermore
that the commonly employed volumes and techniques are
compared. Assessment of the contamination of joint space
and surrounding tissues is also warranted owing to the
potentially noxious or unwanted effects of botulinum toxin,
or the potential chondrolytic effects of corticosteroid
(McAlindon et al., 2017) and local anaesthetics (Piper et al.,
2011). This study aims to determine the intratendinous
distribution and surrounding contamination of commonly
utilised injection volumes and techniques, delivered under
ultrasound guidance, in cadaveric specimens. It was
hypothesised that ultrasound guidance would ensure accur-
ate delivery to the common extensor tendons and that
intratendinous distribution was dose-dependent and im-
proved with fenestrated techniques.
Methods
In this cadaveric study, 20 fresh-frozen, unembalmed
upper-limb specimens from 10 individuals were used.
Age of the specimens ranged from 70 to 96 years, four
were female, and six were male. The specimens were
sectioned at the upper 3rd of the humerus proximally
and radio-carpal joint distally. Specimens had not under-
gone previous upper limb surgery. Information regarding
any history of tendinopathy or other pathological abnor-
malities was not known by the authors. Ethical approval
(REC 17/NW/0065) was obtained from the NHS North
West - Preston Research Ethics Committee.
Injections technique
The specimens were block randomised to receive either
a 1 or 3 ml (ml) injection, delivered using a single pass
or fenestrated technique, yielding four groups of five
specimens. Injection volume was derived from the 25%
and 75% percentile of injection volumes from studies re-
ported in a recent comprehensive systematic review
(Dong et al., 2016). The single pass technique delivered
the injection into the mid portion of the of the anterior
Common Extensor Tendon (CET) origin, corresponding
to the position of the ECRB (Konin et al., 2013) and the
most commonly injected position, the fenestrated
technique used nine passes delivered in a 3 × 3 square
pattern across the anterior CET origin. The injected
material was 2.44% methylene blue; all injections were
delivered using a 5 ml syringe and 21 gauge needle. Injec-
tions were delivered by a Consultant musculoskeletal radi-
ologist, with 6 years’ experience, using a Siemens RS80A
ultrasound machine (Seimens, Munich, Germany) using
a16 MHz transducer in both transverse and longitudinal
planes (Fig. 1). The prosections were positioned with the
elbow flexed to 45–50°. Evidence and size of intrasub-
stance and footprint tendon tears before and after injec-
tion and calcification was quantified using ultrasound.
Anatomic dissection
Following injection the elbows were positioned with the
arm over a bar, mimicking the lateral decubitus position.
The specimen was held with a single clamp on the skin
overlying the triceps muscle. Dissection was preceded by
a dry arthroscopy using a single high proximal antero-
medial portal. The presence of intra-articular joint con-
tamination of injectate was recorded.
Dissection was performed through a posterior midline
incision, with subdermal excursion to the lateral side. Soft
tissue contamination was recorded. The CET was identi-
fied. This was excised proximally subperiosteally to the
lateral epicondyle, and distally at least 1 cm distal to the
musculotendinous interface. The excised CET was trans-
ferred to a dissection table where periosteal tissue was re-
moved from the insertion, the musculotendinous junction
was identified and tissue distal to it removed, leaving the
isolated CET (Fig. 2). The macroscopic appearance of the
CET was digitally photographed and recorded.
Image analysis
The dissected CETs were placed in microtome template
and surrounded with low melting point paraffin wax.
Specimens were stored in the dissection room cold store
at 6 °C for 12 h. The specimens were then mounted in a
bench microtome (Brunel Microscopes Ltd., Chippen-
ham, UK) and were sectioned in an axial plane at 1-mm
intervals. Each section was digitally photographed using
a static high-resolution 12-megapixel camera (Fujifilm,
Tokyo, Japan).
Each digital photograph underwent a two-stage image
analysis process. Semi-automated segmentation of the
tendon border from the wax surround was undertaken
and lighting normalised between sections using the me-
dian intensity of the region outside the tendon/wax spe-
cimen. Following this, algorithmic contour lines
denoting intensity of the dye (i.e. the retention of the
methylene blue from light blue (distributed dye) to dark
blue (concentrated dye) in four increments representing
quartiles of the blue colour spectrum) were overlaid
using the red channel, following light smoothing with a
Evans et al. Journal of Experimental Orthopaedics  (2018) 5:27 Page 2 of 8
Gaussian filter (Fig. 3). The second stage quantified the
total number of pixels denoting the tendon area, and sub-
sequently, the number of pixels within the four incre-
ments of dye intensity was quantified. Pixel number was
transformed to fractional area to allow comparison within
and between the tendon samples. Finally, the slices were
reformatted using the marching cubes algorithm to pro-
vide 3-dimensional representations which were visually
assessed for patterns of injectate spread and pooling.
Statistical analysis
The primary outcome, percentage of pixels, was reported
descriptively using means and standard deviation. Fur-
ther analysis was performed using hierarchical linear re-
gression modelling, with a fixed effect on injection
technique, injection volume, and dye intensity, and a
random effect on the cadaveric specimen, nested within
patients. Each specimen was tested under each of the
two conditions (technique and volume) with pixel per-
centage reported in four gradations (density of blue dye).
Regression coefficients and 95% Confidence Intervals
(CI) are reported and statistically significant differences
in pixel percentage between injection technique and vol-
ume was defined as a global p < 0.05 for catagorical vari-
ables. All statistical analysis was undertaken using Stata
14 (StataCorp. 2015. Stata Statistical Software: Release
14. College Station, TX: StataCorp LP).
Results
Pre-injection ultrasound identified that 60% of the 20 ca-
davers had CET tears, 33% of those tears were located at
the footprint and an average size on ultrasound meas-
urement of 5.8 mm (Range 6-8 mm). Of the eight CETs
without a pre-injection tear, the post-injection ultra-
sound identified a tear in five (62.5%). Intra-tendinous
calcification was evident in seven (53.8%) of the CETs.
Fig. 1 Longitudinal ultrasonogram of the Common Extensor Tendon (CET). The hypodermic needle can been seen entering at the right side of
the image. This particular specimin underwent a 1 ml single shot injection
Fig. 2 Dissected Common Extensor Tendon (CET). Showing non-
articular side. Blue colouration from methylene blue dye injection
Fig. 3 Common Extensor Tendon (CET) held in wax surround of
bench microtome. The four areas of algorithmically derived colour
intensity are seen within each of the four contour lines
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Following injection, intra-articular elbow joint contam-
ination was evident in all 20 specimens on dry arthros-
copy. Macroscopic assessment consequently found
contamination in both the lateral and medial joint space
and on the articular and non-articular sides of the CET.
The appearance of the external surface of all 20 CETs
demonstrated the focus of the dye at the tendon site
with widespread surrounding soft tissue contamination
that diminished in proportion to the distance from the
injection position.
The mean volume (mm3) of the CET specimens, de-
rived from the total pixel density, was 1040mm3
(±371.91 Range 344.72mm3 to 1845.74mm3). When sep-
arated by group (injectate volume or technique), no stat-
istical differences in tendon volume were found.
The mean percentage of intratendinous pixel density,
at the most sensitive dye intensity (lightest blue), was
98.76% (±2.0) for 1 ml and 97.91% (±2.27) for 3 ml,
98.63% (±1.96) for single shot injections and 98.05%
(±2.35) for fenestrated injection. Mean percentage of
blue dye concentration, in the four colour intensities
from lightest blue to darkest blue is shown in Table 1
and graphically in Fig. 4. Statistically significant differ-
ences were found between the groups of blue pixel dis-
tribution against the baseline of group 1 (group 2
regression coefficient − 0.06 (95% CI -0.10 to − 0.02),
group 3–0.21 (− 0.25 to − 0.17) and group 4–0.60 (− 0.61
to − 0.54)) with a global p-value of < 0.001. However, no
statistically significant differences in blue pixel distribu-
tion were found between for the dependent variables in-
jection volume (p = 0.255, 95% CI -0.10 to 0.03) or
injection technique (p = 0.514 95% CI -0.04 to 0.08). Po-
tential differential effects of brightness level for different
injection types and volumes were investigated by
addition of an interaction term between brightness and
injection type/volume (only one interaction term was in-
cluded per model). No differential effects of brightness
across injection type/volume were observed.
3-Dimensional reconstructions of the intratendinous
injectate distributions visually confirmed broad tissue
penetration centred in the midportion of the tendon
with no discernable patterns of longitudinal or
cross-sectional spread or pooling, or a particular ana-
tomical localisation (e.g. to the anterior or footprint
component of the tendon in the position of the ECRB)
(Fig. 5).
Discussion
This study has identified that commonly used elbow in-
jection volumes and techniques, distribute injectate
throughout 97% of the common extensor tendon in ca-
daveric specimens. No differences were found between
injection volumes or techniques. Dye contamination of
the intra-articular surface was noted in every specimen,
and post-injection ultrasound revealed tears to the ten-
don in over 60% of specimens that were previously
uninjured.
This is the first study to assess intratendinous injectate
distribution of the elbow extensors in cadaveric tissue,
although the use of human tissue has greater utility in
its generalisability to a clinical context, the tissue
morphology of cadaveric specimens should be taken into
consideration. The cadaveric tissue utilised in this study
was of subjects with an average age much higher (range
70–96) than the peak age of onset of LET (45-60 yrs),
and though the specimens had no history of elbow sur-
gery, their detailed medical history was not known.
Pre-injection tears were noted in 60% of specimens, and
though the tear rate in asymptomatic individuals is felt
to be very low (Krogh et al., 2017; Ustuner et al., 2013),
the proportion of tears in this study population corre-
sponds to the tear rate seen in tendinopathic individuals,
which has been reported as 57% by Walton et al. (Wal-
ton et al., 2011) and 58% by van Kollenburg et al. (van
Kollenburg et al., 2009). Furthermore, calcification was
noted in over half of specimens, and though the appear-
ance of calcification is a common finding, known to in-
crease with age, it may be of poor diagnostic value in
LET (Jaén-Díaz et al., 2010). Our finding of 53% is equ-
able to asymptomatic 50 yr. olds and is, in fact, lower
than normally reported in those > 70 yrs. (Krogh et al.,
2017). We, therefore, feel that the sample, though lim-
ited in number, is morphologically representative of a
LET population.
Table 1 Mean percentage +/− Standard deviation (SD) of the Blue pixels distributed within the CET tendon from lightest blue to




Lightest blue←→ Darkest blue
Group 1 Group 2 Group 3 Group 4
Mean SD Mean SD Mean SD Mean SD
1 ml 98.76% 2.00% 94.00% 4.01% 79.55% 7.49% 44.04% 12.54%
3 ml 97.91% 2.27% 90.87% 7.92% 74.98% 12.59% 37.83% 15.30%
Single shot 98.63% 1.96% 92.04% 7.26% 74.86% 11.25% 39.21% 10.29%
Fenestrated 98.05% 2.35% 92.82% 5.59% 79.67% 9.32% 42.66% 17.33%
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Previous authors have commented upon the contamin-
ation of the elbow joint and surrounding tissues in lateral
elbow injections (Keijsers et al., 2017; Park et al., 2017).
However, the current literature has either assessed unguided
injections in cadavers, or assessed the distribution on retro-
spective assessment of ultrasound images, without the
known validity of such a method. Ultrasound injection is ad-
vocated in lateral elbow injections to improve accuracy and
decrease contamination rate (Keijsers et al., 2017), but the
present study reports that even with the application of ultra-
sound guidance, the joint contamination rate was 100%.
The target site for elbow injection is the ECRB and though
very challenging to isolate on USS from the CET, its position
is deep and has a delicate and intimately associated connec-
tion to joint capsule, particularly at its anterior edge
(Nimura et al., 2014). The presence of tears in this region
and the propagation or creation of tears with guided injec-
tions may inevitably force the injection into the joint space.
The CET tapers from the musculotendinous junction to
its origin at the lateral epicondyle. Its footprint has been
defined as approximately 10 mm in anteroposterior width
(Nimura et al., 2014), its true tendinous length is approxi-
mately 16 mm (Keijsers et al., 2016), its thickness at the
radiocapitelar joint is 4.4 mm (Toprak et al., 2012), the
average width of the CET at the musculotendinous junc-
tion though not previously defined, was 35 mm in the
Fig. 4 a Bar chart showing the mean percentage of blue pixels in each of the four colour intensity groups for the 1 ml and 3 ml volume
injections. Error Bars = 95% Confidence Intervals. b Bar chart showing the mean percentage of blue pixels in each of the four colour intensity
groups for the single injection and fenestrated injection techniques. Error Bars = 95% Confidence Intervals
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current study. Calculating the volume of an oblique wedge
(Stocker & Harris, 1998) (V ¼ bh6ð2aþcÞ), from these figures
yields a volume of 938.66 mm3, which is similar to the
mean total volume, derived from the pixel density, found
in the current study (1040 mm3). The volume of 1 and
3 ml injections clearly equates to a fluid volume of 1000
and 3000 mm3. Therefore, with localised injection of com-
mon injectate volumes, in an area of densely packed colla-
gen, it is unsurprising that the tendon itself is both
damaged and that the injectate is disseminated down a
path of least resistance. With the delicate anterior capsular
edge presenting as a likely route, joint contamination be-
comes inevitable. Dependent on the injection substance,
this finding may be clinically relevant to the practitioner,
particularly in the context of a patient with an otherwise
pathology free elbow joint.
Cross-sectional analysis of the CET segments, includ-
ing 3-dimensional reformatting, found widespread
dissemination of the injectate dye regardless of volume
or technique, with no apparent pattern or pooling.
Previous cadaveric and animal studies have reported a
preponderance toward longitudinal spreading of injectate
(Belt et al., 1993; Loftus et al., 2012; Wilson et al., 2015),
in line with collagen fibre orientation. However, these
studies have predominantly utilised oval tendons including
lamb distal forearm extensor and flexor tendons (Wilson
et al., 2015) and horse flexor tendons (Belt et al., 1993).
CET tendons were included by Loftus et al. (Loftus et al.,
2012) but as 14% of a cohort of predominantly hamstrings
and patellar tendons, exclusively assessed with ultrasound.
This is the first study to report widespread cross-sectional
spread in the broad flat tendon morphology of the CET,
where tears were either present or induced. Indeed, colla-
gen cross-linking is likely to have been disrupted as part
of the injection process, allowing cross-sectional spread.
The use of needle fenestration has been advocated as a
method of distributing injectate more evenly (Wilson et
al., 2015), however systematic review of CET injections
report conflicting findings of its superiority over single
shot injections (Dong et al., 2016; Fitzpatrick et al.,
2017). This study did not demonstrate any statistical
difference in the cross-sectional distribution of injectate
Fig. 5 Examples of 3-Dimensional reformats of tendon segments for the four injection techniques. From left – tendon boarder, then working
through four colour intensity contours. Note no pattern of pooling or longitudinal spread. (Video examples of the four groups of injections are
available in the Additional file 1)
Evans et al. Journal of Experimental Orthopaedics  (2018) 5:27 Page 6 of 8
between the two techniques using either 1 ml or 3 ml
volumes. Further visual assessment of injectate distribu-
tion on 3D reconstruction did not isolate any noticeable
difference in distribution patterns. It is important to
note that significant escape of active injectate occured
regardless of technique with the volumes used in this
study, and the presented findings may be different if
smaller volumes were employed.
This study has identified that using commonly utilised
injectate volumes and techniques with ultrasound guid-
ance into a cadaveric common extensor tendon can cre-
ate tendon tears and joint contamination may be
inevitable. The structural disruption to the CET seen in
this study raises questions about the potentially destruc-
tive, or indeed therapeutic, effect a large injection vol-
ume may have on the CET. The disruption could be
thought of as analogous to a volumetric debridement,
therein an injection of 1 ml of saline may in itself have a
treatment effect, and in this regard may not be an
appropriate placebo intervention. Though no clinical
evidence of high volume injections efficacy has been
presented in LET, a 2017 randomised controlled trial of
Achilles tendinopathy treatment reported them as superior
to PRP injection and physiotherapy treatment [27]. Further
preclinical and subsequent clinical studies of high and
low volume injections are therefore warranted and future
placebo randomised controlled trials may require a placebo
where no fluid is injected.
Limitations
The authors recognise several limitations present within
this study. Although the number of cadaveric specimens
used in the current study is greater than previously pub-
lished tendon injection studies (Keijsers et al., 2017;
Wiegerinck et al., 2011), the volume and technique
groups are of a small number. However, variability in
injectate distribution was within acceptable limits, and
the statistical methods were appropriate to the small
group, repeated measures design. The use of fresh frozen
cadaveric material, dry arthroscopy, careful dissection
practice and avoidance of freezing techniques for micro-
tome slicing were all employed to reduce the risk of tis-
sue destruction and degeneration not related to the
injection. The choice of methylene blue was made to de-
rive clear visualisation of contamination and to assess
graduated tissue penetration. However, the dye used has
a lower viscosity that some of the commonly used injec-
tate preparations, with particular reference to PRP. Wil-
son et al. (Wilson et al., 2015) reported that there was
no difference in the longitudinal spread of injectate in
lamb tendons injected with pure methylene blue or
methylene blue mixed with PRP. However, they do re-
port cross-sectional distribution was lower in the com-
bined group, and it, therefore, remains a possibility that
that cross-sectional distribution observed in the current
study may be reduced in higher viscosity injectates. The
authors suggest that the volume effect, rather than
viscosity, is likely to have a greater effect on collaged
cross-link disruption.
Conclusion
Both 1 ml and 3 ml injections into cadaveric elbow com-
mon extensor tendons distribute injectate equally across
97% of the intratendinous area, with no difference dem-
onstrated between single-shot or fenestrated injection
techniques. The injection of these volumes into a small
anatomical space may cause damage to the tendon struc-
ture, and due to the close association of this tissue to
the joint capsule, intra-articular elbow joint contamin-
ation may be inevitable, this should be taken into con-
sideration when selecting the injection substance. In
common with all cadaveric studies, the findings pre-
sented cannot be directly translated to invivo applica-
tion, however, in the pursuit of optimal and justified
injection technique, low volume, single shots injections
are warranted clinically as broad distribution of injectate
is likely and the risks of intra-articular joint contamin-
ation reduced.
Additional file
Additional file 1: Example of a three-dimensional rendering of injectate
distribution, showing no clear pattern or injection pooling or longitudinal
injectate spread. (MP4 2766 kb)
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